Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation. (2016)
Attributed to:
Effect of the circadian clock time of day and sleep on the human metabolome: identification of metabolite rhythms
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.mct-15-0815
PubMed Identifier: 27048952
Publication URI: http://europepmc.org/abstract/MED/27048952
Type: Journal Article/Review
Volume: 15
Parent Publication: Molecular cancer therapeutics
Issue: 6
ISSN: 1535-7163